Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30516102

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 Feb 14
First author
von Minckwitz G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2019 Feb;9(2):158-159. doi: 10.1158/2159-8290.CD-NB2018-169.
    note
    Source null
    related pmid
    30541774
    relationship
    Comment in
  2. citation
    N Engl J Med. 2019 Feb 14;380(7):676-677. doi: 10.1056/NEJMe1816059.
    note
    Source null
    related pmid
    30763184
    relationship
    Comment in
  3. citation
    Natl Med J India. 2020 May-Jun;33(3):158-159. doi: 10.4103/0970-258X.314006.
    note
    Source null
    related pmid
    33904420
    relationship
    Comment in
  4. citation
    Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):377-381. doi: 10.1016/j.ijrobp.2022.05.024.
    note
    Source null
    related pmid
    36152640
    relationship
    Comment in

Authors and identifiers

  1. name
    von Minckwitz G
    type
    Author
  2. name
    Huang CS
    type
    Author
  3. name
    Mano MS
    type
    Author
  4. name
    Loibl S
    type
    Author
  5. name
    Mamounas EP
    type
    Author
  6. name
    Untch M
    type
    Author
  7. name
    Wolmark N
    type
    Author
  8. name
    Rastogi P
    type
    Author
  9. name
    Schneeweiss A
    type
    Author
  10. name
    Redondo A
    type
    Author
  11. name
    Fischer HH
    type
    Author
  12. name
    Jacot W
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    von Minckwitz G
    type
    Author
  2. name
    Huang CS
    type
    Author
  3. name
    Mano MS
    type
    Author
  4. name
    Loibl S
    type
    Author
  5. name
    Mamounas EP
    type
    Author
  6. name
    Untch M
    type
    Author
  7. name
    Wolmark N
    type
    Author
  8. name
    Rastogi P
    type
    Author
  9. name
    Schneeweiss A
    type
    Author
  10. name
    Redondo A
    type
    Author
  11. name
    Fischer HH
    type
    Author
  12. name
    Jacot W
    type
    Author
bibliography ids
  1. nci-bib-07d23afe9f89eb8b90553b74
book metadata
content sha256
55a7e36db1942b65b9e71844fb20dc91586fd24f2c22c8cd84e896fa76d1184d
document type
citation
dois
  1. 10.1056/NEJMoa1814017
electronic publication date
display
2018 Dec 5
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30516102
immutable id
pubmed:30516102@55a7e36db1942b65b9e71844fb20dc91586fd24f2c22c8cd84e896fa76d1184d
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
7
name
The New England journal of medicine
nlm unique id
0255562
pages
617-628
volume
380
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2019 Feb;9(2):158-159. doi: 10.1158/2159-8290.CD-NB2018-169.
    note
    Source null
    related pmid
    30541774
    relationship
    Comment in
  2. citation
    N Engl J Med. 2019 Feb 14;380(7):676-677. doi: 10.1056/NEJMe1816059.
    note
    Source null
    related pmid
    30763184
    relationship
    Comment in
  3. citation
    Natl Med J India. 2020 May-Jun;33(3):158-159. doi: 10.4103/0970-258X.314006.
    note
    Source null
    related pmid
    33904420
    relationship
    Comment in
  4. citation
    Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):377-381. doi: 10.1016/j.ijrobp.2022.05.024.
    note
    Source null
    related pmid
    36152640
    relationship
    Comment in
outcomes validated
false
pmid
30516102
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
ee880cc395c21314a7f109055cd3714580bbd16346ce533467ebfd457d2cd764
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2019 Feb 14
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30516102/
title
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.

Preserved source evidence · Not medical advice